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Background: Acute coronary syndrome (ACS) is associated with
emergency hospitalizations, and there are limited real-world data
on clinical outcomes in Asian post-ACS patients. This paper pre-
sents data on the Indian subgroup from the long term follow-up of
antithrombotic management patterns In Acute CORonary Syn-
drome patients in Asia (EPICOR-Asia) study.
Methods: EPICOR included 12,922 patients with ACS (ST-segment
elevation myocardial infarction [STEMI], non-ST-segment eleva-
tion myocardial infarction [NSTEMI], or unstable angina [UA]).
The study had two phases: acute phase and follow-up phase.
The primary objective was to describe short- and long-
term antithrombotic management patterns (AMPs). Secondary
objectives were to compare the association of AMPs with
clinical outcomes of death and cardiovascular (CV) and bleeding
events.
Results: EPICOR-India enrolled 2468 patients (STEMI – 1482;
NSTEMI – 562; UA – 424). CV risk factors were present in 55% of
the population. Pre-hospital care was received by 35% of
patients, and the average time from symptom onset to ﬁrst
medical attention was approximately 7 h. Thrombolysis was
initiated after admission in 29.1% of STEMI patients, whereas
cardiac catheterization was performed in 74% of the overall
population. The most common drug regimen prescribed during
the acute phase was ≥2 antiplatelets + anticoagulants with no GP
IIb/IIIa inhibitors and at discharge were aspirin + clopidogrel.
Post-discharge outcomes at 2 years included death in 166
(6.7% [STEMI – 6.9%; NSTEMI – 9.6%; UA – 2.4%]), CV events in
177 (7.2% [STEMI – 7.9%; NSTEMI – 8.0%; UA – 3.5%]), composite
events of death, MI, or ischemic stroke in 182 (7.4% [STEMI –
7.6%; NSTEMI – 10.9%; UA – 2.1%]), and bleeding events in 7 (0.3%
[STEMI – 0.3%; NSTEMI – 0.2%; UA – 0.2%]).
Conclusion: This study has observed a gap between international
recommendations and implementation for managing ACS in
Indian patients. The poor pre-hospital care, delay in receiving
medical attention, and fewer doctors opting for non-invasive
interventions are some of the challenges in India. The mortality
along with composite events of death, MI, or ischemic stroke was
highest for NSTEMI patients. The reported CV events were similar
in STEMI and NSTEMI groups. Going forward, steps need to be
taken to improve identiﬁcation, diagnosis, and management of
ACS patients to improve patient outcomes.
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Background: Acute coronary syndrome (ACS) is one of the
leading cause of cardiovascular morbidity and mortality world-
wide. Various scoring systems are available for assessing the
severity of ACS. Many serum markers are under investigation to
assess the severity of ACS. Few of them are rather simple to
assess such as platelet-lymphocyte ratio (PLR), neutrophil-lym-
phocyte ratio (NLR), and non-HDL cholesterol levels. Associa-
tion between these markers and severity of ACS has been
studied in the past and few studies have shown positive cor-
relation between these markers and severity of ACS. However
such association is not established in literature on Indian
patients where there is increasing burden of morbidity and
mortality due to ACS.
Aim: To assess serum PLR, NLR, and serum non-HDL cholesterol
levels in patients with acute coronary syndrome (ACS).
Objective:To study the correlation between serumPLR, NLR, serum
non-HDL cholesterol levels, and severity of ACS.
Methods: This is a prospective study on hospitalized patients with
ACS. ACS was diagnosed based on clinical presentation, ECG, and
cardiac biomarkers. Blood for hemogram and lipid levels was
drawn at admission. Coronary angiography was performed
through the femoral artery access and the angiograms were
evaluated by two interventional cardiologists who were blinded
to the study. The severity of ACSwas assessed by Gensini score. A
total of 86 patientswho presentedwith ACS fromFebruary 2014 to
April 2014 at Kasturba Hospital, Manipal were taken into the
study.
Data analysis and interpretation was done with SPSS 20. A
correlation between Gensini score and PLR, NLR, and non-HDL
cholesterol was established using bivariate correlation analysis
and Spearman's coefﬁcients were calculated. The median Gen-
sini score, median PLR, median NLR, and median non-HDL
cholesterol levels were 56.5, 18.4, 4.94 and 133.67 respectively.
Patients were divided into 3 equal groups based on Gensini
score. Patients with Gensini score ≤40 were categorised as mild,
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